Table 3 Multivariate analyses for patient outcomes of NSAIDs use

β

B (95% CI)

VIF

P value

β

B (95% CI)

VIF

P value

Age

-0.111 (-0.519, -0.006)

1.397

0.045

0.065 (-0.181, 0.508)

1.392

0.351

Sex (male)

-0.063 (-3.152, 0.645)

1.100

0.195

0.002 (-2.522, 2.595)

1.100

0.977

BMI

0.072 (-0.129, 0.825)

1.155

0.152

-0.027 (-0.783, 0.502)

1.154

0.667

Hypertension

0.016 (-1.535, 2.105)

1.173

0.758

-0.048 (-3.371, 1.527)

1.170

0.459

Dementia

-0.227 (-9.356, -3.544)

1.248

< 0.001

-0.044 (-5.235, 2.587)

1.246

0.505

Cardiovascular disease

-0.068 (-4.032, 0.762)

1.145

0.172

0.001 (-3.202, 3.208)

1.145

0.999

Cerebrovascular disease

0.042 (-1.534, 3.708)

1.208

0.415

-0.039 (-4.588, 2.469)

1.207

0.555

Upper limb paralysis

-0.028 (-8.041, 4.511)

1.182

0.580

-0.024 (-10.074, 6.831)

1.182

0.706

Femoral Fracture

-0.014 (-3.415, 2.924)

2.780

0.879

-0.112 (-6.369, 2.154)

2.765

0.331

Lumbar Compression Fracture

0.001 (-3.371, 3.673)

2.232

0.933

-0.374 (-13.064, -3.823)

2.063

0.001

Thoracic Compression Fracture

0.063 (-2.188, 5.173)

2.853

0.425

-0.345 (-13.492, -3.828)

2.710

0.001

Pelvic Fracture

0.040 (-2.957, 5.606)

1.974

0.543

-0.187 (-12.263, -0.850)

1.932

0.025

Patellar Fracture

-0.001 (-4.479, 4.431)

1.716

0.992

-0.008 (-6.320, 5.683)

1.716

0.917

FIM-total at admission

-0.697 (-0.655, -0.473)

1.500

< 0.001

-0.223 (-0.311, -0.071)

1.440

0.002

Number of drugs

0.041 (-0.323, 0.724)

1.347

0.451

0.037 (-0.511, 0.898)

1.345

0.589

Acetaminophen use

0.034 (-1.183, 2.441)

1.174

0.495

0.022 (-2.015, 2.866)

1.174

0.732

NSAIDs use

0.127 (0.501, 4.122)

1.184

0.013

0.004 (-2.385, 2.521)

1.184

0.948

Length of stay

-0.046 (-0139, 0.051)

1.204

0.365